This is a working overview of reversed-phase HPLC, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
Tesamorelin binds to growth hormone-releasing hormone receptors on somatotroph cells in the anterior pituitary. Receptor activation increases intracellular cyclic AMP and promotes synthesis and secretion of growth hormone. Because the peptide mimics endogenous GHRH, it amplifies the normal pulsatile release of growth hormone rather than providing exogenous growth hormone directly. This upstream action distinguishes tesamorelin from recombinant growth hormone preparations and from growth hormone secretagogues that act at different receptors.
Stimulated growth hormone release leads to hepatic production of insulin-like growth factor 1, a key mediator of many growth hormone effects. In clinical studies, tesamorelin increased IGF-1 levels in a dose-dependent manner, although the response varies among individuals. The drug's effect on visceral fat is thought to involve growth hormone-mediated lipolysis and altered adipocyte metabolism. Muscle mass and lean body mass have also been assessed as secondary outcomes, but changes are generally smaller and less consistent than fat reductions.
| Property | Value | Notes |
|---|---|---|
| Molecular weight | Approximately 5,136 Da | Based on the 44-amino-acid peptide backbone and N-terminal modification. |
| Appearance | White to off-white lyophilized powder | Usually supplied in single-use vials for reconstitution. |
| Solubility | Freely soluble in water; slightly soluble in some organic solvents | Peptide nature supports aqueous reconstitution. |
| Typical storage | 2–8 °C, protected from light | Refrigeration reduces degradation; avoid freezing unless specified. |
| Common analytical method | Reverse-phase high-performance liquid chromatography | Used for identity, purity, and quantification. |
| Synonyms | Tesamorelin, TH9507, GHRH(1-44) analog | Generic descriptors; avoid proprietary names. |
特沙莫瑞林是一种合成肽，其序列与人生长激素释放激素的 44 个氨基酸形式相关。它在 N 端带有反式-3-己烯酰基修饰，这一改动可减缓二肽基肽酶 IV 的降解。该化合物属于生长激素释放激素受体激动剂，可刺激垂体释放生长激素。研究文献通常将其归入合成肽类药物，而非小分子化合物。
监管记录显示，特沙莫瑞林于 2010 年在美国首次获得批准，用于人类免疫缺陷病毒感染相关的脂肪营养不良患者。批准依据来自降低内脏脂肪的临床试验，而非体重或瘦体重的普遍改善。后续出现了不同制剂版本，但其核心适应症保持一致。关于长期心血管结局和死亡率影响，现有证据仍不充分。
在临床研究之外，特沙莫瑞林常被讨论为生长激素分泌促进剂，但这一说法需要限定。它并不等同于生长激素本身，也不属于普通减重药物。部分研究关注其减少腹部脂肪和改善脂质谱的潜力，另一些研究则关注胰岛素抵抗和 IGF-1 升高等信号。这些效应的临床意义仍在评估中，尚未形成统一结论。
稳定性研究通常考察温度、光照、湿度和 pH 对肽链的影响。冻干粉在低温避光条件下较为稳定，复溶后则需控制保存时间并避免反复冻融。肽类可能发生氧化、脱酰胺、水解和聚集，这些变化会改变色谱纯度。强制降解实验用于识别主要降解途径并验证分析方法的专属性。
质量控制项目一般包括外观、身份、纯度、含量、有关物质、水分和微生物限度。身份确认可通过肽图谱、氨基酸分析和质谱完成，纯度则用面积归一化法计算。研究级材料与药品级材料的要求不同，前者常缺少完整药典验证。不同批次间杂质谱是否影响活性，仍是一个需要具体数据回答的问题。
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
Binding of tesamorelin to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and the release of growth hormone into circulation. Because the peptide acts upstream of the growth hormone axis, its effects are partly mediated by hepatic insulin-like growth factor 1 (IGF-1) production. The pulsatile character of endogenous growth hormone secretion is preserved rather than replaced. Whether amplified signaling produces effects beyond those of native GHRH remains an area of ongoing investigation.
Storage claims vary across suppliers, and published stability data for specific formulations are limited. Extrapolating from related peptides is common but not a substitute for direct measurement. For research use, documentation such as a certificate of analysis is often requested to confirm identity and purity. What constitutes an acceptable purity threshold depends on the intended application. Open questions remain about how temperature excursions during shipping affect long-term peptide integrity. Independent verification by an end user is not routinely reported.
Lyophilized tesamorelin is generally stored refrigerated at 2 to 8 degrees Celsius, protected from light and moisture. Peptides in this class are often kept frozen at minus 20 degrees Celsius for longer periods. Reconstituted solutions are typically used within a defined window because hydrolysis and oxidation proceed faster in liquid form. Container material and headspace also influence how long a preparation retains its expected profile. Specific stability figures depend on concentration and buffer composition.
In July 1974, Fripp, Bruford, and Wetton began recording Red. Before recording began, Fripp, now increasingly disillusioned with the music industry, turned his attention to the works of English mystic John G. Bennett and had a spiritual experience in which "the top of my head blew off". Most of the album had been developed during live improvisations before Fripp "withdrew his opinion", leaving his bandmates to direct the sessions. The album contains one live track, "Providence", recorded on 30 June 1974 in Providence, Rhode Island with Cross on violin. Several guest musicians, including former members Ian McDonald and Mel Collins on saxophones, contributed to the album. Released on 6 October 1974, Red went to No. 45 in the UK and No. 66 in the US. AllMusic later called it "an impressive achievement" for a group about to disband, with "intensely dynamic" musical chemistry between the band members. Two months before the release of Red, King Crimson's future looked bright, with talks regarding the possibility of McDonald rejoining the group. However, Fripp wished not to tour as he felt increasingly disenchanted by the group and the music industry. He also felt the world was going to drastically change by 1981 and that he had to prepare for it. Despite a band meeting while touring the US in which Fripp expressed a desire to end the band, the group did not formally disband until 25 September 1974; the following month Fripp announced in an interview with Trouser Press magazine that King Crimson had "ceased to exist" and was "completely over for ever and ever".
Mrs. Glover, the well-known Scientist, will receive applications for one week from ladies and gentlemen who wish to learn how to heal the sick without medicine, and with a success unequaled by any known method of the present day, at Dr. Kennedy's office, No. 71 South Common Street, Lynn, Mass. Lynn was a center of the shoe industry and most of Eddy's students were factory workers or artisans. She charged $100, raised a few weeks later to $300, for a three-week course of 12 lessons (reduced in 1888 to seven). Eddy based the lessons on a revised version of Quimby's "Questions and Answers" manuscript—now called "The Science of Man, by which the sick are healed, Embracing Questions and Answers in Moral Science"—and on three shorter manuscripts, "The Soul's Inquiry of Man", "Spiritualism", and "Individuality", which she had written for her classes. "Questions and Answers" began: "What is God?" The answer: "Principle, wisdom, love, and truth." Two books on mental healing appeared around that time that may have influenced Eddy's thinking: The Mental Cure (1869) and Mental Medicine (1872), both by Warren Felt Evans, another former patient of Quimby's. Eddy allowed her students to make copies of the manuscripts, but they were forbidden, under a $3,000 bond, from showing them to anyone. The students agreed to pay Eddy 10 percent annually of income derived from her work, and $1,000 if they failed to practice or teach it.
=== 3. Clinical Examples: CAL vs Pseudopocket vs Gingival Enlargement === Patients with clinical attachment loss typically present with features of chronic periodontitis. A common example is a middle-aged adult with deep true periodontal pockets, gingival recession, tooth mobility, furcation involvement, and radiographic evidence of alveolar bone loss. Another example includes localized attachment loss due to aggressive toothbrushing, presenting as cervical recession with exposed CEJ and true pocket formation. Key identifying features include irreversible attachment loss, apical migration of the JE, and true periodontal pocket formation. Pseudopockets are commonly seen in younger patients with plaque-induced gingivitis. For example, a teenager may present with swollen, edematous gingiva, probing depths of 6–10 mm, a hidden CEJ, and no radiographic bone loss. Similarly, patients with orthodontic brackets may develop localized gingival swelling around brackets, resulting in 5–7 mm probing depths without attachment loss. These cases are characterized by false pockets, increased probing depth due solely to gingival swelling, and reversibility with proper plaque control. Gingival enlargement presents differently depending on etiology. Drug-induced cases, such as in patients taking phenytoin or nifedipine, show bulbous, firm, bead-like gingiva with buried CEJs and minimal bleeding on probing. Hormonal enlargement, such as pregnancy epulis, appears as localized, red, soft, and friable gingival masses with partially hidden CEJs and increased sulcus depth.
Sources: en.wikipedia.org
The larynx is a major (but not the only) source of sound in speech, generating sound through the rhythmic opening and closing of the vocal folds. To oscillate, the vocal folds are brought near enough together such that air pressure builds up beneath the larynx. The folds are pushed apart by this increased subglottal pressure, with the inferior part of each fold leading the superior part. Such a wave-like motion causes a transfer of energy from the airflow to the fold tissues. Under the correct conditions, the energy transferred to the tissues is large enough to overcome losses by dissipation and the oscillation pattern will sustain itself. In essence, sound is generated in the larynx by chopping up a steady flow of air into little puffs of sound waves. The perceived pitch of a person's voice is determined by a number of different factors, most importantly the fundamental frequency of the sound generated by the larynx. The fundamental frequency is influenced by the length, size, and tension of the vocal folds. This frequency averages about 125 Hz in an adult male, 210 Hz in adult females, and over 300 Hz in children. Depth kymography is an imaging method to visualize the complex horizontal and vertical movements of vocal folds. The vocal folds generate a sound rich in harmonics. The harmonics are produced by collisions of the vocal folds with themselves, by recirculation of some of the air back through the trachea, or both.
Currently, therapeutic strategies are being studied to help improve the communication between different cells in this pancreatic region by diving deeper into the cellular functions of these very cells and the regions they islet regions they reside in. The current studies being done mainly focus on diabetes and preventing the adverse effects it poses on mammalian organisms. The studies being done now focus heavily on the potential for stem-cell therapeutics or the development of different pharmaceuticals to help limit this condition.
10 December – The Metropolitan Police confirms that Deveca Rose, a 29-year-old mother, whose four children died in a South London house fire in December 2021, has been charged with manslaughter. Rose also faces charges of child abandonment. The skull of a pliosaur has been excavated from the cliffs of Dorset's Jurassic Coast. McDonald's says it has "permanently removed" a "third party security guard" who was filmed the previous day kicking a homeless man's possessions out of the way while mopping the floor outside the food outlet's premises in Victoria Street, London. The footage gained public attention after it was posted on social media. 11 December – Following a trial at the Old Bailey, Ashana Studholme, Lisa Richardson and Shaun Pendlebury are convicted of the September 2022 murder of Shakira Spencer, a west London mother-of-two, who was tortured, starved and beaten to death by the trio. The Association of School and College Leaders (ASCL) and National Association of Head Teachers (NAHT) issue a joint statement calling for the immediate pause of Ofsted inspections following the outcome of the inquest into the death of Ruth Perry. 12 December – Nottingham City Council outlines a programme of cost savings, including the loss of 550 jobs, as it seeks to deal with a £50m deficit. At a meeting with MPs, Sir Adrian Montague, chairman of Thames Water, says that the company cannot afford to repay a £190m loan which is due in April 2024.
Sources: en.wikipedia.org
== Goals of Pharmacometabolomics == Pharmacometabolomics is thought to provide information that complements that gained from other omics, namely genomics, transcriptomics, and proteomics. Looking at the characteristics of an individual down through these different levels of detail, there is an increasingly more accurate prediction of a person's ability to respond to a pharmaceutical compound. The genome, made up of 25 000 genes, can indicate possible errors in drug metabolism; the transcriptome, made up of 85,000 transcripts, can provide information about which genes important in metabolism are being actively transcribed; and the proteome, >10,000,000 members, depicts which proteins are active in the body to carry out these functions. Pharmacometabolomics complements the omics with direct measurement of the products of all of these reactions, but with perhaps a relatively smaller number of members: that was initially projected to be approximately 2200 metabolites, but could be a larger number when gut derived metabolites and xenobiotics are added to the list. Overall, the goal of pharmacometabolomics is to more closely predict or assess the response of an individual to a pharmaceutical compound, permitting continued treatment with the right drug or dosage depending on the variations in their metabolism and ability to respond to treatment. Pharmacometabolomic analyses, through the use of a metabolomics approach, can provide a comprehensive and detailed metabolic profile or "metabolic fingerprint" for an individual patient.
In June 2019, academic Stephen Wertheim called President Trump a "xenophobe" and criticised Trump's foreign policy toward China for heightening risks of a new Cold War, which Wertheim wrote "could plunge the United States back into gruesome proxy wars around the world and risk a still deadlier war among the great powers". In August 2019, Yuan Peng of the China Institute of International Studies said that the 2008 financial crisis "initiated a shift in the global order". Yuan predicted the possibility of the new cold war between both countries and their global power competition turning "from 'superpower vs. major power' to 'No. 1 vs. No. 2'". On the other hand, scholar Zhu Feng said that their "strategic competition" would not lead to the new Cold War. Zhu said that the US–China relations have progressed positively and remained "stable", despite disputes in the South China Sea and Taiwan Strait and US president Trump's aggressive approaches toward China. In January 2020, columnist and historian Niall Ferguson opined that China is one of the major players of this Cold War, whose powers are "economic rather than military", and that Russia's role is "quite small". Ferguson wrote: "[C]ompared with the 1950s, the roles have been reversed. China is now the giant, Russia the mean little sidekick. China under Xi remains strikingly faithful to the doctrine of Marx and Lenin.
Anirudh Ravichander composed Darbar's soundtrack and score, marking his second collaboration with Rajinikanth after Petta (2019) and also with director A. R. Murugadoss after Kaththi (2014). "Thalaivar Theme", an instrumental theme for the film, was released on 7 November 2019 to accompany the motion poster. The film's first single "Chumma Kizhi", whose lyrics were written by Vivek and sung by S. P. Balasubrahmanyam, was released on 27 November 2019. The film's album was launched on 7 December 2019 at Jawaharlal Nehru Indoor Stadium, Chennai, in the presence of the film's cast and crew; it was made available to stream through the online streaming platform Gaana on the same day. The film's soundtrack has an unreleased hidden song titled "Kannula Thimiru", which was recorded by trans-woman singers Chandramukhi, Rachana and Priya Murthi, and was performed live at the film's audio launch. For the song, Anirudh engaged veteran composer Deva to conduct the song's brass section; a making-of video of the song was released in mid January 2020 and went viral on the internet. Sify stated "the soundtrack album is quite disappointing as compared to Rajinikanth's earlier film Petta, due to the unimpressive lyrics but it touches the listener's soul and enables them to sing along".
== Treatment == In most of the reported cases, the treatment options were very similar. Plasmapheresis alone or in combination with steroids, sometimes also with thymectomy and azathioprine, have been the most frequently used therapeutic approach in treating Morvan's Syndrome. However, this does not always work, as failed response to steroids and to subsequently added plasmapheresis have been reported. Intravenous immunoglobulin was effective in one case. In one case, the dramatic response to high-dose oral prednisolone together with pulse methylprednisolone with almost complete disappearance of the symptoms within a short period should induce consideration of corticosteroids. In another case, the subject was treated with haloperidol (6 mg/day) with some improvement in the psychomotor agitation and hallucinations, but even high doses of carbamazepine given to the subject failed to improve the spontaneous muscle activity. Plasma Exchange (PE) was initiated, and after the third such session, the itching, sweating, mental disturbances, and complex nocturnal behavior improved and these symptoms completely disappeared after the sixth session, with improvement in insomnia and reduced muscle twitching. However, one month after the sixth PE session, there was a progressive worsening of insomnia and diurnal drowsiness, which promptly disappeared after another two PE sessions.
Sources: en.wikipedia.org
It is a synthetic peptide analog of human growth hormone-releasing hormone. It is used clinically to reduce excess visceral abdominal fat in adults with HIV-associated lipodystrophy. It works by stimulating pituitary growth hormone release.
Pivotal trials enrolled adults with HIV and excess visceral abdominal fat, often in the context of antiretroviral therapy. Participants were assessed mainly by computed tomography for visceral adipose tissue. The approved indication remains specific to that population.
Long-term effects on cardiovascular events, mortality, and sustained fat distribution are not well established. Most trials measured changes over months rather than years. Open questions also include whether benefits persist after treatment stops.
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Binding stimulates cyclic AMP signaling and growth hormone secretion. This is the same receptor used by endogenous GHRH.